Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 4.29 EUR -6.94% Market Closed
Market Cap: 120.1m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyloris Pharmaceuticals SA
Net Income (Common) Peer Comparison

Comparables:
UCB
TUB

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
Net Income (Common)
-€15.4m
CAGR 3-Years
-29%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
Net Income (Common)
€343m
CAGR 3-Years
-22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
Net Income (Common)
€183.9m
CAGR 3-Years
-18%
CAGR 5-Years
-5%
CAGR 10-Years
10%

See Also

What is Hyloris Pharmaceuticals SA's Net Income (Common)?
Net Income (Common)
-15.4m EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's Net Income (Common) amounts to -15.4m EUR.

What is Hyloris Pharmaceuticals SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-21%

Over the last year, the Net Income (Common) growth was -29%. The average annual Net Income (Common) growth rates for Hyloris Pharmaceuticals SA have been -29% over the past three years , -21% over the past five years .

Back to Top